INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31st May 2015
Net Assets |
£256m |
Net Assets per share |
628p |
Share price |
550p |
Total value of unquoted investments |
£19m |
Total number of portfolio companies |
89 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
7.9 |
Amgen |
7.1 |
Biogen |
6.7 |
Celgene |
6.6 |
Regeneron |
6.1 |
Mylan |
5.8 |
Vertex |
3.4 |
Alexion |
3.2 |
Incyte |
3.0 |
Biomarin |
2.7 |
|
----------- |
Total |
52.5 |
Portfolio Profitability |
% NAV |
Profitable |
54 |
Turning Profitable 2015 |
6 |
Unprofitable |
40 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
90 |
Europe & UK |
10 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
93 |
Unquoted |
7 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
30 JUNE 2015